Carrie L. Bourdow - Aug 2, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Director
Signature
/s/ Robert Crotty, by power of attorney
Stock symbol
NBRV
Transactions as of
Aug 2, 2021
Transactions value $
-$932
Form type
4
Date filed
8/4/2021, 09:04 PM
Previous filing
Jul 30, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Sale -$932 -777 -4.04% $1.20 18.5K Aug 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.205, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.